Search

Author/Creator Hammers, H.

1. 4LBA Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial. (September 2015)

Authors:
Choueiri, T.; Escudier, B.; Powles, T.; Mainwaring, P.; Rini, B.; Donskov, F.; Hammers, H.; Hutson, T.; Roth, B.; Peltola, K.; Lee, J.L.; Heng, D.; Schmidinger, M.; Borgman-Hagey, A.; Hessel, C.; Scheffold, C.; Schwab, G.; Tannir, N.; Motzer, R.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S708
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial. (September 2015)

Authors:
George, S.; Motzer, R.J.; Hammers, H.; Redman, B.; Kuzel, T.; Tykodi, S.S.; Plimack, E.; Jiang, J.; Waxman, I.; Rini, B.I.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search